TEVA
LOW Impact
TEVA
Teva Pharmaceutical Reports Third Quarter 2024 Financial Results
|
8-K
Summary
On November 6, 2024, Teva Pharmaceutical Industries Ltd. announced its financial results for the third quarter of 2024. The company furnished a press release with financial details, which is incorporated by reference from this 8-K report. While the specific financial data and analysis were not provided in the 8-K, the announcement signifies the company's adherence to its regulatory obligations by disclosing key financial outcomes for the period.
Get alerts for TEVA
Be first to know when TEVA files with the SEC.
Filing Categories
General Statement
No viable tag
Exhibits (1)
Advertisement
Official SEC Documents
TEVA Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings
Advertisement